Strategic Acquisition Tepha was acquired by Becton, Dickinson and Company in 2021, positioning it within a major medical technology group and expanding its potential sales channels into broader healthcare markets and large-scale distribution networks.

Innovative Biomaterials Specializing in resorbable polymer technology, Tepha offers unique tissue engineering solutions that address surgeons' needs for advanced, tissue-like biomaterials, ideal for expanding into innovative surgical markets and custom medical applications.

Growth & Expansion Recent executive hires and collaborations, including partnerships with companies like Tornier, indicate an active effort to extend product applications and deepen market penetration in orthopedics and regenerative medicine sectors.

Targeted Market Segment Operating in the medical equipment manufacturing industry with a focus on tissue repair, Tepha presents opportunities to connect with hospitals, surgical centers, and orthopedic specialists seeking resorbable and customizable tissue solutions.

Financial & Market Potential With a revenue range of up to $10 million and substantial funding of $25 million, there is considerable potential for sales growth and new product development within the regenerative medicine space, especially by leveraging its innovative biomaterials and strategic partnerships.